Borsi Seyed Hamid, Shoushtari Maryam Haddadzadeh, Raji Hanieh, Nezhad Hooshmand Hosseini, Mal-Amir Mehrdad Dargahi
Department of Internal Medicine, School of Medicine, Air Pollution and Respiratory Diseases Research Center, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IRN.
Cureus. 2024 Jan 30;16(1):e53244. doi: 10.7759/cureus.53244. eCollection 2024 Jan.
Nosocomial infections pose a significant public health concern, impacting over 100 million people worldwide annually. Within this research, we investigated heparin nebulization through the endotracheal tube and its effect on preventing blockage due to clots and mucus plugs compared to normal saline.
A double-blind clinical experiment was done on a cohort of 40 pneumonia patients who were intubated and hospitalized in the intensive care unit (ICU) at Imam Khomeini Hospital in Ahvaz, Iran. The individuals were randomly assigned to two groups of 20 patients using a random allocation technique. The initial cohort was administered 5000 IU of heparin diluted in 4 ccs of 0.9% normal saline every eight hours via a nebulizer through a tracheal tube. In contrast, the second cohort was given 5 ccs of normal saline as a nebulizer through a tracheal tube. The study compared the incidence of tracheal tube obstruction caused by mucus plug or clot, the occurrence of patient hypoxia resulting in emergency tracheal tube replacement, and the frequency of emergency tracheal tube suction due to partial obstruction caused by mucus plug in both the heparin and saline groups.
According to our data, the number of patients in the heparin group who could avoid the need for emergency tracheal tube replacement owing to blockage was more significant than in the ordinary saline group (P=0.013). Heparin was significantly correlated with the number of times emergency suction was required to remove a tracheal tube occlusion (P=0.01). Heparin had no significant effect on coagulation factors (international normalized ratio [INR], platelet [PLT], and partial thromboplastin time [PTT]), Acute Physiology and Chronic Health Evaluation (APACHE) score, pneumonia severity index (PSI), saturation of patients, or tracheal tube secretions. There was no statistically significant difference in total time spent in the intensive care unit (P=0.91).
Further studies are suggested to determine the effect of heparin nebulization on preventing endotracheal tube obstruction due to clots and mucus plugs in intubated ICU patients.
医院感染是一个重大的公共卫生问题,每年影响全球超过1亿人。在本研究中,我们研究了通过气管内导管进行肝素雾化,并与生理盐水相比,其对预防因血凝块和黏液栓导致的堵塞的效果。
对40名在伊朗阿瓦士伊玛目霍梅尼医院重症监护病房(ICU)插管并住院的肺炎患者进行了一项双盲临床试验。使用随机分配技术将个体随机分为两组,每组20名患者。初始队列通过气管导管每8小时经雾化器给予5000 IU肝素稀释于4 cc 0.9%生理盐水中。相比之下,第二队列通过气管导管给予5 cc生理盐水作为雾化剂。该研究比较了肝素组和生理盐水组中因黏液栓或血凝块导致气管导管阻塞的发生率、患者因缺氧导致紧急更换气管导管的发生率以及因黏液栓导致部分阻塞而进行紧急气管导管抽吸的频率。
根据我们的数据,肝素组中因堵塞而避免紧急更换气管导管的患者数量比生理盐水组更显著(P = 0.013)。肝素与清除气管导管阻塞所需的紧急抽吸次数显著相关(P = 0.01)。肝素对凝血因子(国际标准化比值[INR]、血小板[PLT]和活化部分凝血活酶时间[PTT])、急性生理与慢性健康评估(APACHE)评分、肺炎严重程度指数(PSI)、患者饱和度或气管导管分泌物没有显著影响。在重症监护病房的总住院时间上没有统计学显著差异(P = 0.91)。
建议进一步研究以确定肝素雾化对预防ICU插管患者因血凝块和黏液栓导致气管导管阻塞的效果。